Literature DB >> 9679693

Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia.

M D Kamaliah1, D Zainal, N Mokhtar, N Nazmi.   

Abstract

BACKGROUND: Previous studies have reported that drugs and infections are common causes of erythema multiforme (EM) and Stevens-Johnson syndrome (SJS). Toxic epidermal necrolysis (TEN) is mainly related to drugs. No study has been conducted in Kelantan, the northeastern state of Malaysia, to assess these cutaneous reactions.
METHODS: A retrospective study of all hospitalized cases of EM, SJS, and TEN was conducted covering an 8-year period from 1987 to 1994.
RESULTS: There were four cases (13.8%) of EM, 22 cases (75.9%) of SJS, and three cases (10.3%) of TEN. Drugs as a definitive cause was observed in one case (25%) of EM, 12 cases (54.5%) of SJS, and two cases (66.7%) of TEN. Drugs as a probable cause was observed in seven cases (31.8%) of SJS and one case (33.3%) of TEN. The male to female ratio was equal in EM and SJS. Antiepileptics were the commonest culprits, followed by antibiotics. One patient died of SJS and one patient died of TEN, giving mortality rates of 4.5% and 33.5% respectively. Fever was noted in 18 patients (62.1%). Leukocytosis was noted in 10 patients (34.5%), and nine patients (31.0%) had elevated liver transaminase enzymes. No significant correlation was noted between these biochemical changes and cutaneous eruption. Secondary infections were observed in 11 patients (37.9%): Staphylococcus aureus was the commonest isolated organism.
CONCLUSIONS: This study shows that drugs remain the commonest culprit in SJS and TEN. Despite adequate treatment, the mortality rate remains high, especially in TEN. These findings are similar to those of other reported studies.

Entities:  

Mesh:

Year:  1998        PMID: 9679693     DOI: 10.1046/j.1365-4362.1998.00490.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  10 in total

1.  Of race, ethnicity, and rash: the genetics of antiepileptic drug-induced skin reactions.

Authors:  John W Miller
Journal:  Epilepsy Curr       Date:  2008 Sep-Oct       Impact factor: 7.500

2.  Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population.

Authors:  C-C Chang; C-C Ng; C-L Too; S-E Choon; C-K Lee; W-H Chung; S H Hussein; K-S Lim; S Murad
Journal:  Pharmacogenomics J       Date:  2016-03-01       Impact factor: 3.550

Review 3.  Epidemiology and risk factors for drug allergy.

Authors:  Bernard Y-H Thong; Teck-Choon Tan
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

4.  Clinical, etiologic, and histopathologic features of Stevens-Johnson syndrome during an 8-year period at Mayo Clinic.

Authors:  David A Wetter; Michael J Camilleri
Journal:  Mayo Clin Proc       Date:  2010-02       Impact factor: 7.616

Review 5.  Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis.

Authors:  Stefanie Zimmermann; Peggy Sekula; Moritz Venhoff; Edith Motschall; Jochen Knaus; Martin Schumacher; Maja Mockenhaupt
Journal:  JAMA Dermatol       Date:  2017-06-01       Impact factor: 10.282

6.  Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.

Authors:  P Brent Ferrell; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2008-10       Impact factor: 2.533

7.  New-onset partial epilepsy in adults.

Authors:  Lynn Liu; J Craig Henry
Journal:  Curr Treat Options Neurol       Date:  2009-07       Impact factor: 3.598

8.  Retrospective analysis of Steven Johnson syndrome and toxic epidermal necrolysis over a period of 5 years from northern Karnataka, India.

Authors:  Kikkeri Narayanasetty Naveen; Varadraj V Pai; Vijetha Rai; Sharatchandra B Athanikar
Journal:  Indian J Pharmacol       Date:  2013 Jan-Feb       Impact factor: 1.200

9.  Stevens-Johnson Syndrome and toxic epidermal necrolysis: a multi-aspect comparative 7-year study from the People's Republic of China.

Authors:  Jie Sun; Jin Liu; Qing-Li Gong; Gao-Zhong Ding; Li-Wen Ma; Li-Chao Zhang; Yan Lu
Journal:  Drug Des Devel Ther       Date:  2014-12-12       Impact factor: 4.162

Review 10.  Drug induced exfoliative dermatitis: state of the art.

Authors:  Mona-Rita Yacoub; Alvise Berti; Corrado Campochiaro; Enrico Tombetti; Giuseppe Alvise Ramirez; Andrea Nico; Elisabetta Di Leo; Paola Fantini; Maria Grazia Sabbadini; Eustachio Nettis; Giselda Colombo
Journal:  Clin Mol Allergy       Date:  2016-08-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.